Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was featured in an article titled “Why Regulation of Mobile Medical Apps Isn’t a Bad Thing.”
Following is an excerpt:
The most anticipated document in the history of the booming field of mobile health should be here any day. The Mobile Medical Applications Guidance we’ve been waiting on for the past year could be published any day. Or maybe it won’t be. There is a fierce battle going on over the release of the guidance and anticipation grows every day that it is not released. One of the most vocal, and well-regarded, individuals in the center of the debate is Brad Thompson, a counsel to the mHealth Regulatory Coalition, who has indicated his support of the FDA releasing the guidance immediately. In a recent Mobihealthnews article. Mr. Thompson provides a rational and factual round-up of the reasons why the final guidance should be released now rather than delayed until after a coordinated effort of regulatory agencies to introduce the HIT regulatory framework, as mandated by the FDA Safety Innovation Act of 2012 (FDASIA).